{"id":"https://openalex.org/W91920171","doi":null,"title":"[Effectiveness of steroids for the rash side effect of pemetrexed].","display_name":"[Effectiveness of steroids for the rash side effect of pemetrexed].","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W91920171","mag":"91920171","pmid":"https://pubmed.ncbi.nlm.nih.gov/23306922"},"language":"ja","primary_location":{"id":"pmid:23306922","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23306922","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002119477","display_name":"Hiroshi Ishikawa","orcid":"https://orcid.org/0000-0003-1116-6885","observed_orcids":["https://orcid.org/0000-0003-1116-6885"]},"institutions":[{"id":"https://openalex.org/I4210088324","display_name":"Shizuoka Cancer Center","ror":"https://ror.org/0042ytd14","country_code":"JP","type":"funder","lineage":["https://openalex.org/I4210088324"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Ishikawa","raw_affiliation_strings":["Dept. of Pharmacy, Shizuoka Cancer Center, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Pharmacy, Shizuoka Cancer Center, Japan","institution_ids":["https://openalex.org/I4210088324"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007213536","display_name":"Tomohisa Onishi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomohisa Onishi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091728366","display_name":"Rie Kobayashi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rie Kobayashi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022422935","display_name":"Yasukata Ohashi","orcid":"https://orcid.org/0009-0007-5613-6053","observed_orcids":["https://orcid.org/0009-0007-5613-6053"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasukata Ohashi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103381928","display_name":"Kenichi Suzuki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenichi Suzuki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032337115","display_name":"Nobuyuki Yamamoto","orcid":"https://orcid.org/0000-0002-7342-0853","observed_orcids":["https://orcid.org/0000-0002-7342-0853"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nobuyuki Yamamoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069032597","display_name":"Michihiro Shino","orcid":"https://orcid.org/0009-0009-4645-1118","observed_orcids":["https://orcid.org/0009-0009-4645-1118"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michihiro Shino","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4083,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.78718322,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"40","issue":"1","first_page":"75","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":1.0},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.6840000152587891},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.8500000238418579},{"id":"https://openalex.org/keywords/corticosteroid-prophylaxis","display_name":"corticosteroid prophylaxis","score":0.9679999947547913},{"id":"https://openalex.org/keywords/chemotherapy-side-effects","display_name":"chemotherapy side effects","score":0.7070000171661377},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.35499998927116394}],"concepts":[{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.9645992517471313},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8975071907043457},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.6981325149536133},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.6553049683570862},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.5508277416229248},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5074686408042908},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4774746894836426},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44139599800109863},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.33608075976371765},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3333629071712494},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068437","descriptor_name":"Pemetrexed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005971","descriptor_name":"Glutamates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:23306922","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23306922","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"English Abstract"},{"id":"mag:91920171","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23306922","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4205370568","https://openalex.org/W2309777334","https://openalex.org/W2292437343","https://openalex.org/W2491652081","https://openalex.org/W2964960971","https://openalex.org/W2896449067","https://openalex.org/W2139593370","https://openalex.org/W2719122080","https://openalex.org/W4415058815","https://openalex.org/W7204808440"],"abstract_inverted_index":{"Rash":[0],"is":[1,192],"a":[2,18,116,187,193,212],"common":[3],"side":[4],"effect":[5],"of":[6,25,43,49,54,61,90,119,124,140,166,168,179,190,210,217],"pemetrexed(PEM).":[7],"In":[8],"clinical":[9,222],"trials":[10,223],"overseas,":[11],"patients":[12,75,95],"were":[13,96,104,114],"prescribed":[14],"with":[15,73,214],"dexamethasone(DEX),":[16],"as":[17],"prevention":[19],"against":[20],"skin":[21],"rash.":[22,55,200],"Four":[23],"mg":[24],"DEX":[26],"was":[27,63,70,130,146,157,172],"orally":[28],"administered":[29],"twice":[30],"daily":[31],"on":[32],"the":[33,41,50,57,88,99,109,127,135,143,153,169,180,206,221],"day":[34,37,39],"prior":[35],"to,":[36],"of,and":[38],"after":[40],"infusion":[42],"pemetrexed.":[44],"The":[45,94,122,138,162],"results":[46],"showed":[47],"suppression":[48],"incidence":[51,123,163,207],"and":[52,59,108,132,151,164,174,208],"severity":[53,139,165,209],"However,":[56],"dosage":[58,189],"period":[60],"medication":[62,218],"not":[64,105],"fully":[65],"verified.":[66],"A":[67],"recent":[68],"survey":[69],"conducted":[71],"retrospectively,":[72],"81":[74],"who":[76,103,113],"started":[77],"PEM":[78],"monotherapy":[79],"from":[80],"May":[81],"2009":[82],"to":[83,86,204,220],"August":[84],"2010,":[85],"study":[87,184,213],"effectiveness":[89],"steroid":[91,191],"rash":[92,125,141,167],"prevention.":[93],"classified":[97],"into":[98],"non-administered":[100,128,144,181],"group(47":[101],"patients),":[102,112],"given":[106,115],"DEX,":[107],"prophylaxis":[110,136,154,170],"group(34":[111],"median":[117],"dose":[118],"DEX(2mg\u00d73":[120],"days).":[121],"in":[126,202],"group":[129,145,155,171],"36.2%,":[131],"23.5%":[133],"for":[134,142,152,199],"group.":[137,182],"G1:":[147,158],"27.7%,":[148],"G2:":[149,160],"8.5%;":[150],"it":[156],"20.6%,":[159],"2.9%.":[161],"statistically":[173],"significantly":[175],"lower":[176],"than":[177],"that":[178,186],"This":[183],"shows":[185],"small":[188],"possible":[194],"precautionary":[195],"or":[196],"preventive":[197],"measure":[198],"Therefore,":[201],"order":[203],"reduce":[205],"rash,":[211],"higher":[215],"doses":[216],"similar":[219],"overseas":[224],"should":[225],"be":[226],"conducted.":[227]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}